Trial · NCT01312766
Outcomes13
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Total Number of Oocytes Retrieved | up to 24 days after treatment start | number of oocytes | MEAN | |
| SECONDARY | Mean hMG Dose (Total); | up to 22 days after treatment start | Internationa Units (IU) | MEAN | |
| SECONDARY | Embryo Quality (Percentage of Patients With at Least One Top Quality Embryo) | up to 28 days after treatment start | The population analysed corresponds to the patients who had at least one embryo to be analysed (i.e 120 participants in the hMG-IBSA group and 123 in the Menopur group). Of this, 119 in the hMG-IBSA group and 121 in the Menopur group underwent embryo transfer. | percentage of participants | NUMBER |
| SECONDARY | Positive b-hCG Test | up to 5 weeks after treatment start | percentage of participants | NUMBER | |
| SECONDARY | Controlled Ovarian Stimulation Duration (Days) | up to 23 days after treatment start | days | MEAN | |
| SECONDARY | 17-β Estradiol (E2) Serum Concentration on the Monitoring Day Before hCG Injection; | up to 23 days after treatment start | pg/ml | MEAN | |
| SECONDARY | Implantation Rate | 10-11 weeks after embryo transfer | percentage of embryos transferred | MEAN | |
| SECONDARY | Clinical Pregnancy Rate, | 10 - 11 weeks after embryo transfer | percentage of participants | NUMBER | |
| SECONDARY | Number of Mature (Grade III Metaphase II) Oocytes Retrieved. | at the end of the stimulation. | oocytes | MEAN | |
| SECONDARY | Ratio Mature/Total Number of Oocytes Retrieved. | at the end of the stimulation. | percentage of total oocytes retrieved | NUMBER | |
| SECONDARY | Total Number of Inseminated Oocytes (IVF and ICSI) | on the day of oocyte retrieval | oocytes | MEAN | |
| SECONDARY | Number of Cleaved Embryos | two days after insemination | embryos | MEAN | |
| SECONDARY | Live Birth Rate | 9 months after treatment | percentage of participants | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01312766/outcomes